WHOOP secures $575 million to scale healthspan platform
Wearable technology company WHOOP has raised $575 million in fresh funding at a $10.1 billion valuation, in a round led by venture firm Collaborative Fund. The investment will be used to expand the company’s data-driven healthspan platform, deepen product capabilities, and grow its global footprint in consumer and professional performance markets.
Founded as a performance-focused wearable for elite athletes, WHOOP has evolved into a continuous health-monitoring ecosystem that tracks sleep, recovery, strain, and a broad set of biometric indicators. The latest capital injection signals strong investor confidence in the long-term potential of preventative, personalized health technologies.
From athlete performance to everyday health
The company’s subscription-based model combines a discreet wrist-worn device with advanced physiological data analytics. By analyzing metrics such as heart rate variability, resting heart rate, respiratory rate, and sleep staging, WHOOP provides members with personalized recommendations designed to improve recovery, reduce injury risk, and optimize daily performance.
With this new funding, WHOOP aims to push further into the broader concept of healthspan—the number of years a person remains healthy and active—rather than focusing solely on athletic output. The company is expected to invest heavily in AI-driven insights, new sensor technologies, and partnerships across digital health, sports science, and corporate wellness.
Investor confidence in preventive health and wearables
The round led by Collaborative Fund underscores the growing interest among investors in platforms that blend wearable devices, longitudinal health data, and machine learning. As healthcare systems worldwide face mounting pressure from chronic disease and aging populations, tools that can detect risks earlier and encourage behavior change are attracting significant capital.
Industry observers note that WHOOP now sits among the most highly valued private companies in the digital health and wearable technology sectors. The company’s ability to convert high-frequency biometric data into actionable guidance for both elite athletes and everyday users will be central to its next phase of growth.